European Medicines Agency panel approves scaling up AstraZeneca COVID vaccine production

FILE PHOTO: Needles and a vial of AstraZeneca's vaccine against coronavirus disease (COVID-19) are pictured during a pilot test which aims to apply 20,000 vaccines per day in coming months, at Fira de Montjuic in Barcelona, Spain, April 26, 2021. REUTERS/Nacho Doce

(Reuters) – A panel of the European drug regulator on Monday approved scaling up manufacturing of AstraZeneca’s COVID-19 vaccine.

An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling line for the vaccine, the European Medicines Agency’s human medicines committee said in a statement.

The scaling up is expected to support the continued supply of the vaccine, including for donations to third countries through COVAX.

More Stories